Head of Investor Relations
Praxis Precision Medicines, Inc. (PRAX)Equibles does not estimate personal net worth.
Dan Ferry is recorded as Head of Investor Relations at Praxis Precision Medicines, Inc. (PRAX). Dan Ferry has spoken on 2 earnings calls across 1 company, most recently for Praxis Precision Medicines, Inc. on May 7, 2026. Praxis Precision Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Praxis Precision Medicines, Inc. includes Marcio Souza (CEO and Board Member), Timothy E. Kelly (CFO), Timothy Kelly (CFO) and 7 others.
“These may include statements about the company's future expectations and plans, clinical development timelines, and financial projections. While these forward-looking statements represent Praxis's views as of today, they should not be relied upon as representing the company's views in the future.”
“Good morning, and welcome to the Praxis Precision Medicine's fourth quarter and full year 2025 Financial Results and Business Update Conference Call.”
Biotechnology · Healthcare
Head of Investor Relations
